These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17441261)

  • 21. C-reactive protein and coronary heart disease.
    Foody JM; Gotto AM; Wenger N
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
    [No Abstract]   [Full Text] [Related]  

  • 22. C-reactive protein and coronary heart disease.
    Ridker PM; Koenig W; Fuster V
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257563
    [No Abstract]   [Full Text] [Related]  

  • 23. [A commentary to the article by Dvoráková, Poledne: "An ultrasensitive C-reactive protein assay--a new parameter of a cardiovascular risk" sent from the Laboratory for Aterosclerosis Investigation at IKEM Prague].
    Málek F
    Vnitr Lek; 2004 Nov; 50(11):807-9. PubMed ID: 15648957
    [No Abstract]   [Full Text] [Related]  

  • 24. Health screening packages: the place of measuring C-reactive protein.
    Wong MS
    Singapore Med J; 2006 Oct; 47(10):827-9. PubMed ID: 16990955
    [No Abstract]   [Full Text] [Related]  

  • 25. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?
    Blankenberg S; Yusuf S
    Circulation; 2006 Oct; 114(15):1557-60. PubMed ID: 17030701
    [No Abstract]   [Full Text] [Related]  

  • 28. Biomarkers for prediction of cardiovascular events.
    Ridker PM; Cook NR
    N Engl J Med; 2007 Apr; 356(14):1472-3; author reply 1474-5. PubMed ID: 17415901
    [No Abstract]   [Full Text] [Related]  

  • 29. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
    Falaknazi K; Bagheri N; Taziki O
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early life origins of low-grade inflammation and atherosclerosis risk in children and adolescents.
    Labayen I; Ortega FB; Sjöström M; Ruiz JR
    J Pediatr; 2009 Nov; 155(5):673-7. PubMed ID: 19595364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients.
    Ben-Yehuda O
    J Am Coll Cardiol; 2007 May; 49(21):2139-41. PubMed ID: 17531664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 35. CRP has little incremental value over traditional cardiovascular risk factors in risk stratification.
    Farkouh ME; Bansilal S; Mathew V
    Nat Clin Pract Cardiovasc Med; 2007 Jun; 4(6):290-1. PubMed ID: 17522718
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular risk factors--where do these come from? Interview by Nicola von Lutterotti].
    Assmann G
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():33-4. PubMed ID: 16379234
    [No Abstract]   [Full Text] [Related]  

  • 38. C-reactive protein--to screen or not to screen?
    Mosca L
    N Engl J Med; 2002 Nov; 347(20):1615-7. PubMed ID: 12432050
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
    Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
    Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.